Chase Pharmaceuticals is a US-based biopharmaceutical company focused on developing and improving treatments for neurodegenerative disorders. Chase Pharmaceuticals was acquired by Allergan in November 2016 to enable improved treatment of Alzheimer's disease through the addition of development programs.
| Loading Documents... |
